EC50

    From Longevity Wiki


    The tissue response (y-axis) to an agonist, in log concentration (x-axis), in the presence of different antagonist concentrations. The EC50 of the agonist is represented by the x co-ordinate that corresponds with the half-maximum of the leftmost curve. This is denoted by [A]

    Half maximal effective concentration (EC50) is a measure of the concentration of a drug, antibody or toxicant which induces a biological response halfway between the baseline and maximum after a specified exposure time. More simply, EC50 can be defined as the concentration required to obtain a 50% [...] effect[1] and may be also written as [A]50.[2] It is commonly used as a measure of a drug's potency, although the use of EC50 is preferred over that of 'potency', which has been criticised for its vagueness.[2] EC50 is a measure of concentration, expressed in molar units (M), where 1 M is equivalent to 1 mol/L.

    The EC50 of a graded dose response curve therefore represents the concentration of a compound where 50% of its maximal effect is observed. The EC50 of a quantal dose response curve represents the concentration of a compound where 50% of the population exhibit a response, after a specified exposure duration.

    For clarification, a graded dose response curve shows the graded effect of the drug (y axis) over the dose of the drug (x axis) in one or an average of subjects. A quantal dose response curve shows the percentage of subjects where a response is noted in an all-or-none manner (y axis) over the dose of the drug (x axis).

    For competition binding assays and functional antagonist assays IC50 is the most common summary measure of the dose-response curve. For agonist/stimulator assays the most common summary measure is the EC50.

    The EC50 is also related to IC50 which is a measure of a compound's inhibition (50% inhibition).

    See Also

    References

    1. Chen Z et al.: EC50 estimation of antioxidant activity in DPPH· assay using several statistical programs. Food Chem 2013. (PMID 23265506) [PubMed] [DOI]
    2. Jump up to: 2.0 2.1 Neubig RR et al.: International Union of Pharmacology Committee on Receptor Nomenclature and Drug Classification. XXXVIII. Update on terms and symbols in quantitative pharmacology. Pharmacol Rev 2003. (PMID 14657418) [PubMed] [DOI]